Ken Griffin’s Autonomix Medical AMIX Stock Holding History

Ken Griffin’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-558	Closed	-$20.5K	–	15467
2025 Q1	$20.5K	Sell	558 -1,722	-76%	-$95.2K	﹤0.01%	13125
2024 Q4	$180K	Buy	+2,280	New	+$403K	﹤0.01%	10618

Other funds holding AMIX

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Ken Griffin's AMIX Position: Q2 2025 in Review

Ken Griffin sold out of Autonomix Medical (AMIX) in Q2 2025, closing a stake of 558 shares — an estimated $20.5K sold.

Ken Griffin first reported a position in AMIX in Q4 2024 and held it in 2 quarters. The position peaked at $180K in Q4 2024. 14 funds tracked by Wall St. Rank hold AMIX as of Q2 2025.

Ken Griffin reported no remaining Autonomix Medical position as of Q2 2025 after selling out during the quarter.
Ken Griffin sold 558 Autonomix Medical shares in Q2 2025, an estimated $20.5K.
Ken Griffin first reported a position in Autonomix Medical in Q4 2024 and held it in 2 quarters.
Ken Griffin's Autonomix Medical position peaked at $180K in Q4 2024.
14 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.